Medicare Advantage markets are highly concentrated across the country, according to a new study from KFF. | Medicare ...

The news comes weeks after a cohort of top health insurers agreed to adjust the controversial preapproval process that can ...

Discover why UNH is undervalued despite profitability pressures and how analysts project a return to strong growth by 2026.

Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by next year, the ...

Sarepta's pause on its prescription gene therapy drug for Duchenne muscular dystrophy gives the company time to work with the FDA on reviews. Infusions nationwide will be canceled. Also in the news, ...

Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read ...

Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by January 1, 2026.

Shares of Humana Inc. HUM rose 1.37% to $223.43 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.14% to 6,305.60 and the Dow ...